Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
117.00    -0.40 (-0.34%)
Bid:
115.60
Ask:
117.00
Spread: 1.40 (1.211%)
Market Cap: £208.72m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

Form 8 - Cicor Technologies Ltd.

13 Nov 2025 12:00

RNS Number : 4604H
Cicor Technologies Ltd
13 November 2025
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Cicor Technologies Ltd.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Cicor Technologies Ltd.

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

12 November 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Ordinary (CHF 10.00)

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

Β 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

Β 

TOTAL:

Nil

-

Nil

-

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

A) Interests in ordinary shares in Cicor Technologies Ltd. held by directors and executive leadership team of Cicor Technologies Ltd. and their close relatives and related trusts

Β 

Name

Number of Cicor Technologies Ltd. ordinary shares

Percentage of issued ordinary share capital of Cicor Technologies Ltd. (%)[1]

Daniel Frutig[2]

9,101

0.21

Norma Corio[3]

1,278

0.03

Denise Koopmans[4]

1,685

0.04

Alexander Hagemann

18,534

0.42

Peter Neumann

5,231

0.12

Marco Kechele

2,303

0.05

Total

38,132

0.87

Β 

B) Interests held as options or awards (whether vested or unvested and whether or not subject to conditions) held by directors and executive leadership team of Cicor Technologies Ltd. in ordinary shares in Cicor Technologies Ltd.

Β 

Name

Scheme under which granted

Date of grant

Price at grant (exercise price) (CHF)

Number of ordinary shares

Vesting date

Expiry date

Daniel Frutig

N/A[5]

17 April 2025

Nil

1,093

16 April 2026

N/A

Norma Corio

N/A[6]

17 April 2025

Nil

875

16 April 2026

N/A

Denise Koopmans

N/A[7]

17 April 2025

Nil

875

16 April 2026

N/A

Alexander Hagemann

PSOP 2022-2024

1 January 2022

52.80

4,032

31 December 2024[8]

31 December 2028

PSOP 2023-2025

1 January 2023

42.90

6,743

31 December 2025[9]

31 December 2029

PSOP 2024-2026

1 January 2024

49.80

22,430

31 December 2026

31 December 2030

PSOP 2025-2027

1 January 2025

60.00

23,726

31 December 2027

31 December 2031

PSP 2023-2025

1 January 2023

Nil

4,578

31 December 2025[10]

N/A

PSP 2024-2026

1 January 2024

Nil

10,892

31 December 2026

N/A

PSP 2025-2027

1 January 2025

Nil

9,340

31 December 2027

N/A

Special PSP

1 September 2025

Nil

2,324

31 December 2027

N/A

Peter Neumann

PSOP 2023-2025

1 January 2023

42.90

3,372

31 December 2025[11]

31 December 2029

PSOP 2024-2026

1 January 2024

49.80

11,691

31 December 2026

31 December 2030

PSOP 2025-2027

1 January 2025

60.00

12,513

31 December 2027

31 December 2031

PSP 2023-2025

1 January 2023

Nil

2,288

31 December 2025

N/A

PSP 2024-2026

1 January 2024

Nil

5,676

31 December 2026

N/A

PSP 2025-2027

1 January 2025

Nil

4,926

31 December 2027

N/A

Special PSP

1 September 2025

Nil

2,008

31 December 2027

N/A

Marco Kechele

PSOP 2023-2025

1 January 2023

42.90

3,372

31 December 2025[12]

31 December 2029

PSOP 2024-2026

1 January 2024

49.80

10,059

31 December 2026

31 December 2030

PSOP 2025-2027

1 January 2025

60.00

10,826

31 December 2027

31 December 2031

PSP 2023-2025

1 January 2023

Nil

2,288

31 December 2025

N/A

PSP 2024-2026

1 January 2024

Nil

4,884

31 December 2026

N/A

PSP 2025-2027

1 January 2025

Nil

4,262

31 December 2027

N/A

Special PSP

1 September 2025

Nil

2,008

31 December 2027

N/A

Β 

C) Interests in ordinary shares in Cicor Technologies Ltd. held by OEP 80 B.V.

Β 

Name

Number of Cicor Technologies Ltd. ordinary shares

Percentage of issued ordinary share capital of Cicor Technologies Ltd. (%)

OEP 80 B.V.

1,881,026

42.86

Β 

Β 

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

Β 

Name

Agreement, arrangement or understanding

Number of Cicor Technologies Ltd. ordinary shares held by relevant person(s) that the agreement, arrangement or understanding relates to[13]

Percentage of issued ordinary share capital of Cicor Technologies Ltd.

Daniel Frutig[14]

Contractual agreement to not dispose of shares for a three-year period ending 18 April 2026

1,220

0.03

Contractual agreement to not dispose of shares for a three-year period ending 19 April 2027

1,479

0.03

Contractual agreement to not dispose of shares for a three-year period ending 18 April 2028

1,962

0.04

Norma Corio[15]

Contractual agreement to not dispose of shares for a three-year period ending 19 April 2027

493

0.01

Contractual agreement to not dispose of shares for a three-year period ending 18 April 2028

785

0.02

Denise Koopmans[16]

Contractual agreement to not dispose of shares for a three-year period ending 18 April 2026

407

0.01

Contractual agreement to not dispose of shares for a three-year period ending 19 April 2027

493

0.01

Contractual agreement to not dispose of shares for a three-year period ending 18 April 2028

785

0.02

Alexander Hagemann

Contractual agreement to not dispose of shares for a three-year period ending 1 September 2028

1,179

0.03

Peter Neumann

Contractual agreement to not dispose of shares for a three-year period ending 1 September 2028

1,018

0.02

Marco Kechele

Contractual agreement to not dispose of shares for a three-year period ending 1 September 2028

1,018

0.02

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

Β 

Β 

Date of disclosure:

13 November 2025

Contact name:

Lukas NΓ€nni

Telephone number:

+41 71 913 73 09

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 


[1] Β Excludes treasury shares. Percentages have been given to two decimal places.

[2] Shares are held through Daniel Frutig, his close relatives (Eva Frutig, Anna Frutig) and an associated company (EvolutionF AG).

[3] Shares are jointly held by Norma Corio and her close relative (Lawrence Corio).

[4] Shares are held through an associated company (K+Co Consulting GmbH).

[5] These shares were awarded as part of the overall remuneration package for the board of directors for the 2025-2026 financial year.

[6] As above.

[7] As above.

[8] The vesting date for these options based on applicable scheme rules is as stated. However, in practice, board approval of satisfaction of applicable conditions in respect of these options took place in 18 April 2025 and the stated number of options vested thereafter.

[9] For options granted under the PSOP, vesting of the relevant options is subject to board approval based on the satisfaction of applicable conditions, which may take place later than 31 December of the relevant year.

[10] For shares granted under the PSP, vesting of the relevant shares is subject to board approval based on the satisfaction of applicable conditions, which may take place later than 31 December of the relevant year.

[11] As above.

[12] As above.

[13] Agreements, arrangements or understandings set out in this table relate to shares held by the relevant person(s) as disclosed under section 3(A) above.

[14] Shares are held through Daniel Frutig, his close relatives (Eva Frutig, Anna Frutig) and an associated company (EvolutionF AG).

[15] Shares are jointly held by Norma Corio and her close relative (Lawrence Corio).

[16] Shares are held through an associated company (K+Co Consulting GmbH).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FEEBJBBTMTABBPA
Date   Source Headline
23rd Oct 20242:25 pmRNSHolding(s) in Company
22nd Oct 202412:38 pmRNSHolding(s) in Company
2nd Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 202411:31 amRNSHolding(s) in Company
23rd Sep 20247:00 amRNSHolding(s) in Company
20th Sep 202411:31 amRNSHolding(s) in Company
16th Sep 20247:00 amRNSTrading Update
2nd Sep 20244:43 pmRNSTotal Voting Rights
2nd Sep 20249:00 amRNSNon-Executive Director Succession for AGM 2025
22nd Aug 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSHalf-Year Results
1st Aug 20242:23 pmRNSTotal Voting Rights
29th Jul 20243:44 pmRNSDirector Declaration
24th Jul 202411:39 amRNSDirector Declaration
1st Jul 20243:00 pmRNSTotal Voting Rights
28th Jun 20247:00 amRNSNED Appointment
26th Jun 20242:00 pmRNSNew Reporting Structure
4th Jun 20245:08 pmRNSDirector/PDMR Shareholding
3rd Jun 20242:52 pmRNSTotal Voting Rights
20th May 20245:00 pmRNSHolding(s) in Company
16th May 20243:18 pmRNSHolding(s) in Company
10th May 20243:10 pmRNSAnnual General Meeting Results
10th May 20247:00 amRNSAGM Trading Update
1st May 20242:19 pmRNSBlock listing six monthly return
1st May 20242:16 pmRNSTotal Voting Rights
9th Apr 20247:00 amRNSCapital Markets Event
4th Apr 20245:40 pmRNSAnnual Financial Report
2nd Apr 20247:00 amRNSCompletion of Divestment
19th Mar 20244:44 pmRNSLong Term Incentive Plan
19th Mar 20248:15 amRNSNon-Executive Director Change
15th Mar 20248:30 amRNSDeferred Share Bonus Plan
12th Mar 20249:01 amRNSDeferred Share Bonus Plan
12th Mar 20249:00 amRNSLong Term Incentive Plan
7th Mar 20247:00 amRNSFull Year Results
4th Mar 20247:00 amRNSDivestment of selected business units
1st Mar 20242:25 pmRNSTotal Voting Rights
15th Feb 20243:59 pmRNSTotal Voting Rights
26th Jan 20248:54 amRNSHolding(s) in Company
25th Jan 202411:32 amRNSHolding(s) in Company
22nd Jan 20244:53 pmRNSHolding(s) in Company
3rd Jan 202411:24 amRNSTotal Voting Rights
4th Dec 20239:02 amRNSTotal Voting Rights
24th Nov 202310:36 amRNSDirectorate Change
22nd Nov 20237:00 amRNSTrading Update
15th Nov 20238:36 amRNSBlock Listing Application
3rd Nov 20232:48 pmRNSHolding(s) in Company
30th Oct 20234:45 pmRNSBlock Listing Six Monthly Return
25th Oct 20238:33 amRNSHolding(s) in Company
11th Oct 20238:40 amRNSHolding(s) in Company
2nd Oct 20232:40 pmRNSShare Awards for Incoming Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.